The TNFRSF17 gene gives instructions for BCMA, a protein on certain immune cells that helps plasma cells survive and make antibodies. If it does not work properly, your body may make fewer antibodies, which can lead to repeated sinus, lung, or other infections. In medicine, this gene is important because its BCMA protein is also a target for newer treatments used in multiple myeloma, a cancer of plasma cells. Some people know the TNFRSF17 gene mainly from those BCMA-targeted cancer treatments.
What is a gene?
A gene is a stretch of DNA that carries instructions your cells use to make molecules or guide processes in the body. Some genes hold the directions for building proteins, which are the parts of cells that do the work. Other genes mainly control when certain processes happen, where they happen, and how strongly they run. Together, genes affect how the body develops and functions, and they can shape how you respond to food, stress, or medicines. For a deeper look at this topic, you can read more in the LearnHub.
Overview
TNFRSF17Gene function
What if the gene works
The TNFRSF17 gene helps plasma cells survive and keep making antibodies. Its protein receives signals that support antibody producing B cells and lasting immune protection.
Risk
What if the gene does not work
Variants in the TNFRSF17 gene can reduce plasma cell survival and antibody production, leading to an antibody deficiency with recurrent infections. Effects can range from milder immune problems to earlier, more persistent infections with lower immunoglobulin levels.
Treatment
What does that mean for your treatment
No TNFRSF17-specific treatment or drug selection approach is currently established for people with a pathogenic or loss-of-function variant in the TNFRSF17 gene. TNFRSF17 is also known as BCMA and is an established treatment target in multiple myeloma, but that use is separate from inherited TNFRSF17 variants.
Gene function
What if the gene works
Some immune cells need steady signals so they can keep making antibodies over time. The TNFRSF17 gene helps with this, mainly in late stage B cells called plasma cells. Its normal role is to let these cells sense nearby immune messages and keep contributing to routine immune protection.
The TNFRSF17 gene helps antibody making plasma cells receive survival signals. This supports long lived cells in the bone marrow that continue producing protective antibodies.
Its protein sits on the cell surface and binds APRIL and BAFF, two immune messengers. These signals are passed inward so the cell can stay active and function in a controlled way.
By helping plasma cells persist, the TNFRSF17 gene supports longer term antibody responses after infection or vaccination. This is a key part of what the TNFRSF17 gene does in plasma cells during everyday immune defense.
What is a variant?
A genetic variant is a minor change in the DNA sequence of a gene. These changes are common and help shape normal differences among people, including appearance, metabolism, and the way the body responds to environmental influences. Many variants have no noticeable effect and are simply part of natural genetic variation. Sometimes, though, a variant changes how a gene functions more substantially and may contribute to or cause a genetic condition.
Genetic variants
What if the gene does not work
Variants in the TNFRSF17 gene can change the BCMA protein so it folds poorly, is cut short, does not reach the cell surface, or cannot bind its partner molecules well. This is the main pattern behind how TNFRSF17 gene variants affect protein function: reduced or absent cell signaling, meaning weaker message passing inside the cell. Milder variants may leave some activity, while more severe variants can make the protein unstable or nearly switch this signaling off.
How variants are linked to conditions
Changes in the TNFRSF17 gene do not yet have a broadly confirmed link to a specific inherited health condition, and research on how TNFRSF17 variants are linked to conditions is still developing. Anyone with a confirmed TNFRSF17-related finding should use their own doctor’s or genetic counselor’s advice to understand what that result may mean for their health.
A variant is not necessarily a diagnosis
Genetic variants are common across the general population and are a normal feature of human biology. Most do not directly affect health and simply contribute to the natural variation seen among people. For many genes, having a variant associated with a condition points to a possible link rather than confirming that condition, particularly when several genes and environmental influences also play a role. Still, in certain situations, one well-characterized variant in a particular gene is enough to establish the diagnosis.
Are there things that can increase or change my risk?
There is not yet broadly confirmed evidence on specific factors that increase or reduce health risk related to the TNFRSF17 gene. For many living with a TNFRSF17 change, risk depends mainly on the exact genetic finding rather than clear lifestyle factors, so discussing personal results with a doctor or genetic counselor is the best next step.
Inheritance of TNFRSF17 variants
There is not yet a broadly confirmed disease specific inheritance pattern for the TNFRSF17 gene, so TNFRSF17 gene inheritance is not described as a clear autosomal dominant, autosomal recessive, or X linked condition at this time. The TNFRSF17 gene is located on chromosome 16, which is an autosome, so each person inherits one copy from each parent. As research grows, the picture may become clearer for any inherited health effects linked to this gene.
What does my TNFRSF17 result mean for my family?
There isn't yet a broadly confirmed inheritance pattern tied to a specific condition for TNFRSF17, though this understanding can change as research develops. If you have a specific TNFRSF17 result and questions about what it could mean for your family, a doctor or genetic counselor can help explain it in the context of your own result.
Genetic information
Genetic testing
How you find out about variants
Genetic testing for TNFRSF17 gene variants usually uses DNA from a blood or saliva sample. A lab reads the TNFRSF17 gene to look for spelling changes in the DNA and compares them with known variants. Results may show no relevant variant, a benign variant, a variant of uncertain significance, or a pathogenic variant.
When should I consider getting a genetic test?
There is not yet a broadly established TNFRSF17-specific reason for genetic testing for most people. If someone has unexplained repeated infections, very low antibody levels, or a strong family history of immune problems, a doctor or genetic counselor may consider this gene as part of broader testing.
A genetic result is only one part of your health story
A genetic result can provide useful insight, but the amount it can tell you varies with the condition and the kind of variant involved. Over time, many factors, including lifestyle, environment, age, and medical history, affect how the body functions. In some cases, a genetic result may give a clear answer. For other conditions, especially those shaped by many genes, genetic information offers context rather than certainty and is best interpreted alongside the rest of a person’s care. In areas like medication response, genetic results can also help put individual experiences into context.
Pharmacogenetics
How variants shape your response to medicine
Genetic variation can affect how people respond to medicines. Small differences in genes can change how the body breaks down a drug, moves it through the body, or reacts to it at the treatment target. This helps explain why the same medicine may work well for one person, work less well for another, or cause more side effects in someone who is more sensitive to it.
What is Pharmacogenetics?
Pharmacogenetics is the area of study that examines how genetic differences affect the way people respond to medications. It focuses on connections between genes and drugs to help explain why the same treatment may work differently from one person to another. For many medicines, genes influence either how strongly a drug works or how the body handles it. This information can support treatment decisions that are more informed and more individualized. More detail on this topic is available in the LearnHub.
Drugs influenced by the TNFRSF17 gene
When should I seek medical advice?
There is not yet a broadly confirmed role for this gene in guiding medication choices. If you have questions about side effects, treatment response, or how your medicines fit with your overall health, talk with your doctor or pharmacist.
History
Researchers identified the TNFRSF17 gene in the 1990s while studying signals involved in B cell development, and it soon became known by the name BCMA. Initially understood only through visible traits, later recognized as tied to a specific gene, this work helped place TNFRSF17 within a broader family of immune system genes. From these first observations, research expanded steadily. Interest grew further when scientists linked TNFRSF17 closely to multiple myeloma cells, which made it an important marker in blood cancer research. In recent years, the gene entered a new phase of attention as BCMA became a major target for newer myeloma treatments, including CAR T cell therapy and bispecific antibodies. This shift moved TNFRSF17 from a research finding to a gene with clear clinical importance.